Dr. Renczes is a physician and co-founder of Auxiliis and has been working in the field of clinical pharmacology for over 20 years. He started his career as an investigator at a university-based Phase I unit, and gradually became the deputy head of the Unit. Later he joined a CRO with dual responsibilities: built, developed and headed the first enterprise-based Phase I research unit in Hungary while overseeing the traditional trial management activities of the company as its medical director and helping the company to reach a market leader position in Hungary. He is also undertook study monitoring duties both at a regional CRO and a big pharma company, thus gaining clinical trials experience from different perspectives. He is a regular lecturer at courses on clinical pharmacology and he published more than 20 papers and 8 book chapters. . He is an invited tutor of the CEMDC Pharmatrain course and also invited tutor of Semmelweis University (Budapest, Hungary) and the University of Miskolc (Miskolc, Hungary). Currently Dr. Renczes currently serves as QA director of the company.

 clinical research and clinical trails